论文部分内容阅读
本文通过回顾性研究对小剂量ＨＡ方案［高三尖杉（Ｈｏｍ）加阿糖胞苷（Ａｒａ－Ｃ）］在急性髓细胞系白血病（ＡＭＬ）和骨髓增生异常综合征（ＭＤＳ－ＲＡＥＢＴ）治疗中的作用进行了总结。１临床资料 自１９９１年起我科ＡＭＬ和ＭＤＳ患者共４４例接受了小剂量ＨＡ方案治疗
In this review, we retrospectively studied the effects of low dose HA regimen [Hom and Ara-C] in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS-RAEBT) The role of the summary. 1 clinical data since 1991, our department AML and MDS patients in 44 cases received a small dose of HA regimen